Hukumar Magungunan Magunguna ta Turai (EMA) ta amince da gwamnatin ga yara masu shekaru 12 zuwa 17 na allurar rigakafin Covid-19, Moderna. Har zuwa yanzu, allurar Pfizer ce kawai ke da wannan izinin.

Moderna, allurar mRNA ita ce allurar rigakafi ta biyu da aka fi gudanarwa a Faransa bayan Pfizer, tare da 6.368.384 (tarin allurar farko da ta biyu) mutane sun yi allurar rigakafi a cewar CovidTracker. Don haka wannan shine ɗayan dalilan da yasa dakin gwaje -gwajen Amurka ya sanya kansa a farkon Yuni don neman izini akan yankin mu. Dangane da binciken da aka yi kwanan nan wanda kamfanin fasahar kere-kere na Amurka ya buga a ranar 25 ga Mayu, an nuna magani kan Covid-19 "Mai inganci sosai", wato kashi 93% a tsakanin matasa masu shekaru 12 zuwa 17. Wanda ake kira TeenCOVE, binciken dakin gwaje -gwaje na Moderna ya ƙunshi mahalarta fiye da 3 da "Babu wata damuwa game da amincin sa har zuwa yanzu", ya fayyace dakin gwaje -gwaje.

"Kwamitin Samfuran Magunguna don Amfani da Dan Adam (…) na AEM sun ba da shawarar ba da ƙarin nuni ga allurar Covid-19 Spikevax (tsohon Covid-19 Vaccine Moderna) don haɗa amfani da shi a cikin yara masu shekaru 12 zuwa 17", In ji mai kula da Turai a cikin sanarwar manema labarai.

A karkashin tashin bambancin Delta, cutar ta Covid-19 ba a shirye take ta daina ba. A Turai yaduwarsa kusan kashi 26%ne, adadi mai yuwuwa ya tashi a nan gaba kuma fiye da ninki biyu a cikin makonni huɗu masu zuwa. Hakanan Amurka tana cikin wannan kololuwar, tare da yaduwar Covid-19 kusan 60%.